This study covers the long-term follow-up of patients who received retroviral or lentiviral-based gene therapy or gene-marked products at St. Jude Children's Research Hospital within the past 15 years. It included patients who had received such treatment. It is an observational (non-phase) follow-up study and has been completed.
The summary above is a plain-language rendering of the official record. The original English title is shown for reference.
Criteria are reproduced from the ClinicalTrials.gov record in the original English. Only the trial team can determine eligibility.
Inclusion Criteria: * Has received an integrating retroviral or lentiviral vector based GT/GM product at St. Jude Children's Research Hospital within the past 15 year time period. Patient is no later than 15 years post receipt of GT/GM product.